Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 3/20 | 0.60 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.58 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.52 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.52 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.52 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.52 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.52 |
| ▸ | LGALS3 | P17931 | 5/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.49 |
| ▸ | OGA | O60502 | 1/20 | 0.47 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.46 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7152294 | 1.00 | LGALS8 (0.60) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL7152720 | 1.00 | LGALS8 (0.60) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL3156075 | 1.00 | LGALS8 (0.60) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL3152068 | 0.96 | LGALS8 (0.58) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL7150592 | 0.96 | LGALS8 (0.58) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL13380951 | 0.93 | LGALS8 (0.53) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL6947007 | 0.93 | LGALS8 (0.53) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL25084120 | 0.92 | LGALS8 (0.66) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL20671054 | 0.92 | LGALS8 (0.66) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL20658674 | 0.92 | LGALS8 (0.66) | LGALS8SLC6A2SSTR1SSTR2SSTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020033971-A1 | USE OF IGF-2 RECEPTOR AGONIST LIGANDS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM | NEW YORK UNIVERSITY (US) | 2020-02-13 | — | — | WO | disclosed |
| WO-2020033972-A1 | USE OF MANNOSE 6 PHOSPHATE AND MODIFICATIONS THEREOF FOR MEMORY ENHANCEMENT AND REDUCING MEMORY IMPAIRMENT | NEW YORK UNIVERSITY (US) | 2020-02-13 | — | — | WO | disclosed |